KALBE FARMA

2019 2018 2017

Liquiditas
Current Ratio 4.35 4.66 4.51
Quick Ratio 2.90 3.14 2.91
Asset Management
Inventory Turnover Ratio 6.06 6.07 5.67
Days Sales Outstanding 59.63 58.43 53.67
Fixed Assets Turnover Ratio 2.95 3.37 3.78
Total Assets Turnover Ratio 1.12 1.16 1.21
Debt Management
Debt Ratio 12% 13% 13%
Times-Interest-Earned Ratio 84.18 111.18 89.06
Profitability
Operating Margin 17% 18% 20%
Profit Margin 11% 12% 12%
ROA 12% 14% 15%
ROE 12% 17% 18%
ROIC 11% 14% 15%
BEP Ratio 17% 18% 20%
Market Value
P/E Ratio
Market/Book Ratio
Industry
Average

1.74
1.11

5.28
0.000
#DIV/0!
0.83

1
#DIV/0!

8%
32%
3%
#DIV/0!
#DIV/0!
6%

#DIV/0!
#DIV/0!
 2019 2018
Current Assets 11,222,490,978,401 10,648,288,386,726
Current Liability 2,577,108,805,851 2,286,167,471,594
Inventory 3,737,976,007,703 3,474,587,231,854
Sales 22,633,476,361,038 21,074,306,186,027
Receivables 3,697,660,122,083 3,373,569,270,404
Net Fixed Assets 7,666,314,692,908 6,252,801,150,475
Total Assets 20,264,726,862,584 18,146,206,145,369
Debt 2,755,333,082,147 2,258,789,235,208
Common Equity 20,264,726,862,584 15,294,594,796,354
EBIT 3,402,616,824,533 3,306,399,669,021
Interest Charge 40,420,271,275 29,738,266,966
Net Income 2,513,242,403,090 2,552,706,945,624
Invested Capital
Tax 865,015,000,888 809,137,704,264
Capital 23,020,059,944,731 17,553,384,031,562

3,306,399,669,021
26% 24%
 2017
10,042,738,649,964
2,227,336,011,715
3,557,496,638,218
20,182,120,166,616
2,967,693,268,440
5,342,659,713,054
16,616,239,416,335
2,060,708,170,409
13,894,031,782,689
3,241,186,725,992
36,391,625,753
2,442,945,312,378

787,935,315,388
15,954,739,953,098

3,241,186,725,992
24%
 Kimia Farma Phapros Pyridam Farma
Current Assets 7344787.12 1198693.66 95946.42
Current Liability 7392140.28 2096719.18 27198.12
Inventory 2849106.18 361927.29 44269.89
Sales 9400535.48 1105420.2 247114.77
Receivables
Net Fixed Assets
Total Assets 18352877.13 2096719.18 190786.21
Debt 9041448.92 1115502.57 24972.11
Accounts Payable 1290414.13 120673.79 8493.65
Notes Payable 5226775.25 994828.78 10404.47
Long term Debt 2524259.54 6073.99

Common Equity
EBIT 501655.74 191584.75 15281.15
Interest Charge
Net Income -12724 102033.53 9342.72
Invested Capital
Tax
Capital
 Indofarma Darya Varia Kimia Farma Phapros
829103.6 Liquiditas
440827.01 Current Ratio 1.0 0.6
148108.54 Quick Ratio 0.6 0.4
1359175.25 Asset Management
Inventory Turnover Ratio 3.30 3.05
Days Sales Outstanding 0 0
1383935.19 Fixed Assets Turnover Ratio #DIV/0! #DIV/0!
348344.24 Total Assets Turnover Ratio 0.51 0.53
229722.2 Debt Management
118622.04 Debt Ratio 1.0 1.0
Times-Interest-Earned Ratio #DIV/0! #DIV/0!
Profitability
Operating Margin 5% 17%
50055.22 Profit Margin -3% 53%
ROA 0% 5%
7960.96 ROE #DIV/0! #DIV/0!
ROIC
BEP Ratio 3% 9%
Market Value
P/E Ratio
Market/Book Ratio
Pyridam Farma Indofarma Average

3.5 1.9 1.7

1.9 1.5 1.1

5.58 9.18 5.3

0 0 0
#DIV/0! #DIV/0! #DIV/0!
1.30 0.98 0.829195

1.0 1.0 1
#DIV/0! #DIV/0! #DIV/0!

6% 4% 0.081336
61% 16% 32%
5% 1% 0.025673
#DIV/0! #DIV/0! #DIV/0!
#DIV/0!
8% 4% 0.058743

#DIV/0!
#DIV/0!